Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes

Journal of Clinical Psychiatry

Volumn 75, Issue 10, 2014, Pages 1088-1095

  Santucci, Aimee K ^a   Singer, Lynn T ^b   Wisniewski, Stephen R ^c   Luther, James F ^c   Eng, Heather F ^c   Dills, John L ^c   Sit, Dorothy K Y ^d   Hanusa, Barbara H ^e   Wisner, Katherine L ^f  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; BAYLEY SCALES OF INFANT DEVELOPMENT; BEHAVIORAL RATING SCALE; CHILD BEHAVIOR; CHILD DEVELOPMENT; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DEVELOPMENT; MENTAL DEVELOPMENT INDEX; MENTAL FUNCTION ASSESSMENT; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREGNANCY; PRENATAL DRUG EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; PSYCHOMOTOR DEVELOPMENT INDEX; PUERPERAL DEPRESSION; PUERPERIUM; CHEMICALLY INDUCED; CLINICAL TRIAL; DEPRESSIVE DISORDER, MAJOR; DRUG EFFECTS; LONGITUDINAL STUDY; PHYSIOLOGY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD DEVELOPMENT; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INFANT; LONGITUDINAL STUDIES; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 84922391924     PISSN: 01606689     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/JCP.13m08902     Document Type: Article

References (40)

1. Reefhuis J, Rasmussen SA, Friedman JM. Selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354(20):2188-2190, author reply 2188-2190. doi:10.1056/NEJMc060602 PubMed
2. Oberlander TF, Gingrich JA, Ansorge MS. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther. 2009;86(6):672-677. doi:10.1038/clpt.209.201 PubMed
3. Yonkers KA, Gotman N, Smith MV, et al. Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? Epidemiology. 2011;22(6):848-854. PubMed
4. Einarson A, Schachtschneider AK, Halil R, et al. SSRIs and other antidepressant use during pregnancy and potential neonatal adverse effects: impact of a public health advisory and subsequent reports in the news media. BMC Pregnancy Childbirth. 2005;5(1):11. doi:10.186/1471-2393-5-1 PubMed
5. Wadhwa PD. Psychoneuroendocrine processes in human pregnancy influence fetal development and health. Psychoneuroendocrinology. 2005;30(8):724-743. doi:10.1016/j.psyneuen.205.02.04 PubMed
6. Zuckerman B, Bauchner H, Parker S, et al. Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Behav Pediatr. 1990;11(4):190-194. doi:10.1097/04703-19080-06 PubMed
7. Deave T, Heron J, Evans J, et al. The impact of maternal depression in pregnancy on early child development. BJOG. 2008;115(8):1043-1051. doi:10.1/j.1471-0528.208.01752.x PubMed
8. Laplante DP, Brunet A, Schmitz N, et al. Project Ice Storm: prenatal maternal stress affects cognitive and linguistic functioning in 5 1/2-year-old children. J Am Acad Child Adolesc Psychiatry. 2008;47(9):1063-1072. doi:10.1097/CHI.0b013e31817ec80 PubMed
9. Robinson M, Oddy WH, Li J, et al. Pre-and postnatal influences on preschool mental health: a large-scale cohort study. J Child Psychol Psychiatry. 2008;49(10):1118-1128. doi:10.1/j.1469-7610.208.0195.x PubMed
10. Ansorge MS, Morelli E, Gingrich JA. Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci. 2008;28(1):199-207. doi:10.1523/JNEUROSCI.3973-07.208 PubMed
11. Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med. 1997;336(4):258-262. doi:10.1056/NEJM197012360404 PubMed
12. Misri S, Reebye P, Kendrick K, et al. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am J Psychiatry. 2006;163(6):1026-1032. doi:10.176/api.ajp.163.6.1026 PubMed
13. Pedersen LH, Henriksen TB, Bech BH, et al. Prenatal antidepressant exposure and behavioral problems in early childhood: a cohort study. Acta Psychiatr Scand. 2013;127(2):126-135. doi:10.1/acps.12032 PubMed
14. Casper RC, Fleisher BE, Lee-Ancajas JC, et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr. 2003;142(4):402-408. doi:10.1067/mpd.203.139 PubMed
15. Casper RC, Gilles AA, Fleisher BE, et al. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacology (Berl). 2011;217(2):211-219. doi:10.107/s0213-01-270-z PubMed
16. Pedersen LH, Henriksen TB, Olsen J. Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics. 2010;125(3):e600-e608. doi:10.1542/peds.208-365 PubMed
17. Hanley GE, Brain U, Oberlander TF. Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect. Early Hum Dev. 2013;89(8):519-524. doi:10.1016/j.earlhumdev.2012.12.012 PubMed
18. Johnson KC, LaPrairie JL, Brennan PA, et al. Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry. 2012;69(8):787-794. doi:10.101/archgenpsychiatry.2012.160 PubMed
19. Oberlander TF, Papsdorf M, Brain UM, et al. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch Pediatr Adolesc Med. 2010;164(5):444-451. doi:10.101/archpediatrics.2010.51 PubMed
20. Wisner KL, Sit DK, Hanusa BH, et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry. 2009;166(5):557-566. doi:10.176/api.ajp.208.0808170 PubMed
21. First M, Spitzer R, Williams J, et al. Structured Clinical Interview for DSM-IV Disorders (SCID). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1994.
22. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
23. Keller MB, Lavori PW, Friedman B, et al. The Longitudinal Interval Follow-up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987;44(6):540-548. doi:10.101/archpsyc.1987.0180180509 PubMed
24. Bayley N. Bayley Scales of Infant Development. 2nd ed. San Antonio, TX: Psychological Corporation; 1993.
25. Jacobson J, Jacobson S. Methodological considerations in behavioral toxicology in infants and children. Dev Psychol. 1996;32(3):390-403. doi:10.1037/012-1649.32.3.390
26. Sodhi MSK, Sanders-Bush E. Serotonin and brain development. Int Rev Neurobiol. 2004;59:111-174. doi:10.1016/S074-742(04)5906-2 PubMed
27. Nichols RA. Serotonin, presynaptic 5-HT? receptors and synaptic plasticity in the developing cerebellum. J Physiol. 2011;589(pt 21):5019-5020. doi:10.13/jphysiol.201.219782 PubMed
28. Cicchetti D, Cohen D. Developmental Epidemiology. In: Costello E, Angold A, eds. Developmental Psychopathology: Theory and Method. 2nd ed. New York, NY: Wiley; 2006:42-69.
29. Coatsworth J. A Developmental Psychopathology and Resilience Perspective on 21st Century Competencies. Washington, DC: National Research Council; 2010.
30. Field T. Prenatal depression effects on early development: a review. Infant Behav Dev. 2011;34(1):1-14. PubMed
31. O'Connor TG, Heron J, Glover V; Alspac Study Team. Antenatal anxiety predicts child behavioral/emotional problems independently of postnatal depression. J Am Acad Child Adolesc Psychiatry. 2002;41(12):1470-1477. doi:10.1097/04583-202120-019 PubMed
32. O'Connor TG, Heron J, Golding J, et al; Report from the Avon Longitudinal Study of Parents and Children. Maternal antenatal anxiety and children's behavioral/emotional problems at 4 years: report from the Avon Longitudinal Study of Parents and Children. Br J Psychiatry. 2002;180(6):502-508. doi:10.192/bjp.180.6.502 PubMed
33. Stifter C, Braungart J. The regulation of negative reactivity in infancy: function and development. Dev Psychol. 1991;31(3):448-455. doi:10.1037/012-1649.31.3.48
34. Forcada-Guex M, Pierrehumbert B, Borghini A, et al. Early dyadic patterns of mother-infant interactions and outcomes of prematurity at 18 months. Pediatrics. 2006;118(1):e107-e114. doi:10.1542/peds.205-145 PubMed
35. Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry. 2009;31(5):403-413. doi:10.1016/j.genhospsych.209.04.03 PubMed
36. Palmsten K, Hernandez-Diaz S. Can nonrandomized studies on the safety of antidepressants during pregnancy convincingly beat confounding, chance, and prior beliefs? Epidemiology. 2012;23(5):686-688. doi:10.1097/EDE.0b013e318258fb2 PubMed
37. Hanna EZ, Faden VB, Dufour MC. The motivational correlates of drinking, smoking, and illicit drug use during pregnancy. J Subst Abuse. 1994;6(2):155-167. doi:10.1016/S089-3289(94)90181-3 PubMed
38. Bessa MA, Mitsuhiro SS, Chalem E, et al. Underreporting of use of cocaine and marijuana during the third trimester of gestation among pregnant adolescents. Addict Behav. 2010;35(3):266-269. doi:10.1016/j.adbeh.209.10.07 PubMed
39. Narkowicz S, Potka J, Polkowska Z, et al. Prenatal exposure to substance of abuse: a worldwide problem. Environ Int. 2013;54:141-163. doi:10.1016/j.envint.2013.01.01 PubMed
40. Oberlander TF, Misri S, Fitzgerald CE, et al. Is polypharmacy associated with transient neonatal symptoms following prenatal psychotropic medication exposure? Pediatr Res. 2003;4(4, pt 2):426A.